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doi:10.1
984Objectives: Endoscopic thoracic sympathectomy can predictably eliminate the disabling symptoms of palmar
hyperhidrosis. Debate has ensued over competing techniques, in particular, cutting versus clamping of the sym-
pathetic chain. We subjectively assessed the sweat severity in different areas of the body and evaluated changes
in the quality of life in patients undergoing either the cutting or clamping technique.
Methods: Patients examined between June 2003 and March 2007 were asked to quantify the severity of their
symptoms before and after endoscopic thoracic sympathectomy. The interviews were conducted approximately
1 year after the procedure. Only the patients undergoing sympathectomy at the T3 level for a chief complaint of
palmar hyperhidrosis were included in the analysis (n ¼ 152). In 45% of these patients, clamping of the sym-
pathetic chain was performed, and the remaining 55% had the chain cut.
Results:After surgery, no patients had continued excessive sweating of the hands. Of all the patients, 95%were
satisfied with the results after the cutting procedure and 97% were satisfied after clamping. No difference was
seen in any outcome between the patients undergoing clamping versus cutting of the sympathetic chain, includ-
ing sweating on the hands, face, armpits, feet, trunk, and thighs or in the quality of life.
Conclusions:We found high rates of success and patient satisfaction when T3 sympathectomy was performed
for palmar hyperhidrosis, with no differences found between the cutting and clamping techniques. (J Thorac
Cardiovasc Surg 2010;140:984-9)Approximately 1% of whites1 are affected by chronic pal-
mar hyperhidrosis that is unprovoked by any mental or
physical stressor and is greatly exacerbated by anxiety. Fur-
thermore, the effects of profuse hand sweating on patients’
professional and social lives cause significant decrement to
their quality of life (QOL).2 Despite the current lack of
understanding of the etiology or pathophysiology of
hyperhidrosis, several methods for surgical sympathectomy
have been used to treat patients with severe palmar hyperhi-
drosis.3 The most important factor influencing patient
satisfaction and improvement in QOL using any of these
procedures has been the appearance of postoperative com-
pensatory sweating (CS). Occasionally, the CS is so severe
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The Journal of Thoracic and Cardiovascular Surgmight regret having undergone endoscopic thoracic sympa-
thectomy (ETS) and wish to have it reversed. No clinical
parameters are available that accurately predict which pa-
tients will experience severe CS.
Recent studies have examined how variations in the
method of sympathectomy can alter the results4,5; however,
no agreement has been reached regarding the method of
ETS. Sympathectomy at the T2 level or at multiple levels
has been associated with a greater incidence of severe CS,
and consensus has been growing that limiting the extent of
sympathectomy will maximize patient satisfaction and
minimize the risk of severe CS.6,7 The surgical technique
has also varied in the method of sympathectomy, and the
debate has continued concerning the risks and benefits of
cutting versus clamping the nerve. Cutting the sympathetic
nerve ensures relief of palmar hyperhidrosis; however, this
precludes the potential for reversal in the event of severe
CS. An alternative is to place surgical clips on the
sympathetic chain, which immediately interrupts the nerve
conduction, but can be removed if the patient is unsatisfied
with the results. Not all patients who undergo clamp
removal will experience a reversal of CS. Several studies
have shown good results with clamping at various levels,8-10
and one study contrasted the effects of cutting and clamping
at multiple thoracic levels.11 However, no single study has di-
rectly compared the long-term effects of cutting versus
clampingwhen the sympathectomy has been restricted to T3.
Given these factors, an essential needexists for comparisons
of the efficacy, incidence of CS, effects on QOL, and patientery c November 2010
TABLE 1. Endoscopic thoracic sympathectomy group characteristics
HDSS Pre-ETS After clamping After cutting
Hands
None (1) 0 (0) 0 (0) 0 (0)
Mild (2) 1 (0.7) 0 (0) 1 (1)
Moderate (3) 12 (8.3) 9 (14.3) 3 (4)
Severe (4) 126 (91) 54 (85.7) 72 (95)
Face
None (1) 52 (39.7) 21 (34) 31 (45)
Mild (2) 58 (42.3) 28 (45) 30 (43)
Moderate (3) 15 (11.5) 8 (13) 7 (10)
Severe (4) 6 (4.6) 5 (8) 1 (1)
Blushing
None (1) 48 (41.4) 26 (42) 22 (41)
Mild (2) 46 (39.7) 22 (35) 24 (44)
Moderate (3) 19 (16.4) 12 (19) 7 (13)
Severe (4) 3 (2.6) 2 (3) 1 (2)
Armpits
None (1) 14 (10) 5 (8) 9 (12)
Mild (2) 44 (33) 23 (38) 21 (28)
Moderate (3) 31 (23) 14 (23) 17 (22.7)
Severe (4) 46 (34) 18 (30) 28 (37.3)
Feet
None (1) 3 (2.1) 0 (0) 3 (4)
Mild (2) 10 (7) 4 (6) 6 (8)
Moderate (3) 34 (25) 20 (32) 14 (19)
Severe (4) 90 (66) 39 (62) 51 (69)
Trunk
None (1) 62 (47.7) 25 (40) 37 (54)
Mild (2) 56 (43.1) 32 (52) 24 (35)
Moderate (3) 11 (8.5) 4 (6) 7 (10)
Severe (4) 1 (0.8) 1 (2) 0 (0)
Thighs
None (1) 54 (50.9) 30 (48) 24 (55)
Mild (2) 46 (43.4) 28 (45) 18 (41)
Moderate (3) 5 (4.7) 3 (5) 2 (5)
Severe (4) 1 (0.9) 1 (2) 0 (0)
QOL (score)
Not affected (1) 0 (0) 0 (0) 0 (0)
Mildly affected (2) 3 (2.1) 1 (2) 2 (3)
Moderately affected (3) 29 (20.9) 18 (29) 11 (14)
Severely affected (4) 107 (77) 44 (70) 63 (83)
Data are presented as number (%). HDSS, Hyperhidrosis disease severity scale; ETS,
endoscopic thoracic sympathectomy; QOL, quality of life.
Abbreviations and Acronyms
CS ¼ compensatory sweating
ETS ¼ endoscopic thoracic sympathectomy
HDSS ¼ hyperhidrosis disease severity scale
QOL ¼ quality of life
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Ssatisfaction both across and within studies of 1 or more varia-
tions to the surgical technique.We administered pre- and post-
operative questionnaires regarding the subjectively assessed
sweat production, QOL, and overall satisfaction to a cohort
of 152 patients with severe palmar hyperhidrosis who under-
went T3 ETS either by cutting or clamping.
MATERIALS AND METHODS
The local institutional review board approved the present study. Be-
tween June 2003 and March 2007, 152 patients (82 females; median age,
25 years; range, 12-56 years) with severe palmar hyperhidrosis underwent
T3 ETS at New York Presbyterian Hospital. The baseline subjective sweat
characteristics are listed in Table 1. From June 2003 to February 2005, all
patients underwent the T3 cutting procedure; however, our technique then
changed to sympathetic nerve clamping, and this technique was performed
on all patients until the end of our study period. The surgical technique was
identical in all patients. In those undergoing clamping, a 5-mm hemoclip
was placed above and below the third ganglion in the same location as
the nerve was cut in those patients for whom cutting was performed.
Evaluations were performed using the hyperhidrosis disease severity
scale (HDSS).12,13 All patients completed the HDSS and a separate QOL
evaluation preoperatively. A postoperative surgical questionnaire was
completed by all patients (median, 488 days from surgery; range, 172-
1159 days) and included the HDSS, QOL evaluation, and overall patient
satisfaction. The QOL assessment was made from an adapted version of
the Liebowitz Disability Self-Rating Scale.14 The HDSS uses a scale of
1 to 4, with 1¼ none, 2¼mild, 3¼moderate, and 4¼ severe. The patients
were asked to rate the sweating on their face, hands, feet, armpits, trunk,
and thighs. Using the same scale, the patients reported how greatly hyper-
hidrosis had affected their QOL, with 1 indicating a significant decrease
and 4 indicating no effect on QOL. Additionally, the preoperative interview
measured the baseline characteristics and included a history of medical
treatment of hyperhidrosis. The patients were considered to have CS in
a body region if an increase in sweating had occurred of 1 point on the
HDSS for that area.
Our surgical technique used two 5-mm ports. A 5-mm hemoclip was
placed across the interganglionic segment of the sympathetic trunk, imme-
diately inferior to the third and fourth ribs. In patients in whom the nerve
was cut, the sympathetic chain was divided immediately below the third
and fourth nerve in the exact location at which the nerve in the other group
was clamped.
When measuring the effects of surgery, while pooling across the clamp-
ing and cutting procedures, the P values were derived using a 2-tailed Wil-
coxon signed rank test. The tests for differences between cutting and
clamping were performed using the nonparametric Wilcoxon rank sum
test. No corrections were made for multiple testing. All data were analyzed
using the Statistical Analysis System software (SAS Institute Inc, Cary,
NC).
RESULTS
No deaths, major surgical complications, or occurrences
of Horner syndrome occurred. Of the 152 patients whoThe Journal of Thoracic and Cacompleted both the pre- and the postoperative question-
naires within the accepted dates, some chose not to answer
particular questions. These were not included in the number
of responders in the present analyses. In 100% of patients,
ETS decreased the severity of hand sweating, and in 93%, it
increased the QOL (Figure 1). A mixture of increases, de-
creases, and no changes in sweating or facial blushing
was evident for other regions. Although not the indication
for surgery, 63% of patients reported a decrease in plantar
sweating, 60% reported a decrease in axillary sweating,
and 35% experienced a decrease in facial blushing. Onrdiovascular Surgery c Volume 140, Number 5 985
FIGURE 1. Patients were asked to judge the severity of sweating, severity of facial blushing, and quality of life (QOL) at the initial interview and again
approximately 1 year postoperatively. The difference between these scores was used as an index of the change, or lack, in symptoms or QOL. For all body
regions, except the hands, variable effects of surgery occurred—some patients experienced increases, some decreases, and others had no change in symptom
severity.
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Sthe thighs and trunk, 61% and 74%, respectively, reported
an increase in sweating.
Data from the postoperative questionnaire from these pa-
tients is listed in Table 2, in which patients were stratified by
the technique used (cutting or clamping). As expected, ETS
had the most pronounced effect on hand sweating, quanti-
fied as a subjective reduction in hand sweating. However,
most importantly, no significant difference was detected be-
tween the clamping and cutting procedures. All patients hadTABLE 2. Quantified effects of ETS on subjective sweat severity
All patients Clamping Cutting n (P value)
Hands
Pre-ETS 3.90 2.85 2.93
Post-ETS 1.25 0.14 0.35
Difference 2.64 2.71 2.57 145 (.441)
Armpits
Pre-ETS 2.79 1.75 1.82
Post-ETS 1.88 0.86 0.87
Difference 0.92 0.88 0.95 146 (.566)
Feet
Pre-ETS 3.53 1.69 1.78
Post-ETS 2.75 2.55 2.52
Difference 0.78 0.85 0.74 143 (.443)
Trunk
Pre-ETS 1.61 1.73 1.60
Post-ETS 2.69 0.69 0.55
Difference 1.08 1.03 1.04 136 (.692)
Thighs
Pre-ETS 1.55 1.30 1.30
Post-ETS 2.33 0.59 0.5
Difference 0.78 0.70 0.80 112 (.178)
QOL
Pre-ETS 1.64 0.65 0.62
Post-ETS 3.74 2.68 2.80
Difference 2.10 2.03 2.17 145 (.627)
Data are presented as mean values. Abbreviations as in Table 1.
986 The Journal of Thoracic and Cardiovascular Surgreported that hyperhidrosis impaired their QOL at baseline,
and most reported that the effect was severe (Table 1). After
surgery, the patients in the clamping and cutting groups both
reported greatly improved QOL. Again, no significant dif-
ferences were observed between the 2 groups.
Next, we sought to identify differences in sweating after
either cutting or clamping of the sympathetic chain for other
body regions and for patient satisfaction (Table 3). The data
indicated no significant differences between cutting and
clamping across all parameters, including patient satisfaction
(Tables 2 and 3). Our final analysis confirmed the presence of
CS, with an incidence comparable between the cutting and
clamping groups across all body regions (Table 4).
DISCUSSION
In the presented analysis, we quantified the changes in the
patterns of sweating approximately 1.5 years after ETS for
palmer hyperhidrosis and found highly favorable results for
nearly all 152 patients. Our results support T3 ETS as anTABLE 3. Post-ETS questionnaire: Comparison of cutting and
clamping
Cutting
(%)
Clamping
(%)
P
value
Are you satisfied with the results of surgery?
Yes 95 97 .741
Have you experienced any new sweating
since surgery?
Yes 62 70 .365
Would you recommend the procedure to
family?
Yes 96 94 .619
Based on the results, would you do the
procedure again?
Yes 96 94 .394
ETS, endoscopic thoracic sympathectomy.
ery c November 2010
TABLE 4. Increased sweating after ETS stratified by technique
Region Cutting (n) Clamping (n) P value
Face 20 (29%) 13 (21%) .05
Feet 4 (5%) 5 (8%) .06
Armpits 9 (12%) 5 (8%) .35
Trunk 50 (74%) 45 (73%) .24
Thighs 33 (75%) 33 (53%) .14
Blushing 10 (19%) 7 (11%) .85
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Seffective treatment of intractable palmar hyperhidrosis,
with a high rate of patient satisfaction and minimal side ef-
fects. Maximizing patient satisfaction requires a balance be-
tween the relief of palmar sweating and the emergence of
CS. It is well established that the development of severe
CS negatively affects patient satisfaction. Despite finding
CS in at least 1 part of the body in 87% of our patients,
with 4% reporting severe CS, 97% were satisfied with
the results of surgery.
Our analysis identified no preoperative marker to predict
the appearance or severity of CS in either treatment group.
The severity of preoperative sweating on the thighs or trunk
was not a reliable predictor of developing severe CS or an
improvement in QOL. Currently, no method is available
to stratify the patients into groups that would predict the
risk of severe CS, coincidental decreases in plantar or axil-
lary sweating, and so forth. However, studies quantifying
the outcomes of sympathectomy will not only engender
more informed physicians and patients, but might also
lead to the emergence of predictors of the postoperative re-
sults. Several lines of research are evaluating ETS and de-
veloping hypotheses about the relationship between the
surgery and its outcomes; however, the debate over their in-
terpretations is ongoing.
Several hypotheses have been presented to explain the ap-
pearance ofCS.Chou and colleagues8 have proposed amech-
anism for CS in which higher sympathetic blockades (i.e.,
above T3) disrupt a large number of afferent inhibitory fibers
that normally function to dampen hypothalamic sudomotor
output. Under this hypothesis, increased rates of CS would
depend on the level of cutting or clamping and not on the
extent of denervation. A contending proposal has posited
that it is the location of symptoms (i.e., facial hyperhidro-
sis/blushing) and not the level of sympathectomy (i.e., T2-
T3 vs T3 alone) that influences the degree of CS.5,15 It is
possible that both views are partially correct and that both
the patient group and surgical technique used are 2 among
many factors that influence the surgical outcomes. With
consideration of these issues, the cause of CS is not known
and accurate hypotheses to explain this phenomenon are
difficult to form without an understanding of the neural
basis for palmar hyperhidrosis.
Our cohort permitted an opportunity to compare 2
methods of sympathectomy, cutting and clamping of theThe Journal of Thoracic and Casympathetic chain at the T3 level. Our motivation for using
the clamping technique was the potential to remove the
clips in a second surgery if the patient was dissatisfied
with the results. Removing clips from the sympathetic chain
has been shown to reverse the results of the initial surgery in
approximately 50% of cases when performed promptly.16
However, it must be noted that no formal study of the rever-
sal surgery has been performed, and these results must be
interpreted with caution. Many surgeons prefer full ablation
or cutting of the sympathetic nerve to ensure interruption of
the sudomotor signals that lead to palmar sweating. How-
ever, ablation or cutting is done at the expense of having
the potential to reverse the surgery in the event that severe
CS results. A disadvantage of the clamping method is the
potential loss of efficacy over time. However, our data
indicated no significant differences in any of our measures,
including the decrease in hand sweating, the appearance of
CS, patient satisfaction, or the effect of ETS on QOL be-
tween cutting and clamping.
A limitation of the present study that should be consid-
ered was the availability of a large group of patients who
had undergone reversal of the clamping surgery. Data
from these patients would be highly valuable when inform-
ing patients regarding the success rates of reversal. How-
ever, because of the rare incidence of such cases, this is
difficult to quantify. From the findings we have presented,
we recommend the use of surgical clamps restricted to T3
for palmar hyperhidrosis and call for additional studies to
replicate our results in larger patient groups.References
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Dr M. Blair Marshall (Washington, DC). Thank you for an
excellent presentation and for getting me both your talk and
your manuscript in advance. In discussing sympathectomy, differ-
ent groups do it different ways. You state that it is a T3 sympathec-
tomy, but you clipped or cut at 2 levels. Could you clarify the
definition of what you think T3 is or what one would consider
a T3 and T4 sympathectomy?
Dr Ibrahimiye. In our method, we clip immediately inferior to
the third and the fourth ribs, isolating the third interganglionic seg-
ment of the sympathetic trunk. I think in other studies, they used
the term ‘‘T3-T4 sympathectomy’’ for the procedure that we did.
DrMarshall. This was a retrospective review. It was unclear to
me how many patients responded to your survey. Did you have
100% follow-up? Was it every patient followed up exactly at 1
year after their sympathectomy or was the survey sent out at one
point for all patients?
Dr Ibrahimiye. The survey was sent out to all patients at one
point, but the patients responded at different intervals. Also, the
follow-up was 100%, but not all patients responded to all the ques-
tions. You might have seen in the manuscript that for different
parts of the body, especially postoperatively, the patients chose
not to answer some questions. That is the reason for the discrep-
ancy in the manuscript. We only included the patients who
responded.
DrMarshall. In your survey you describe trunk or thigh sweat-
ing, but you did not differentiate between the groin or behind the
knees, which can be problematic for many patients. Do you think
that patients understand the meaning of trunk sweating, and what
do you do if you have horrific groin sweating? How do you respond
to your questionnaire?
Dr Shrager. You probably do not know whether patients knew
what you meant by trunk. I do not know how he could answer that.
DrMarshall. I have found when I discuss compensatory sweat-
ing (CS) with patients, if you use the word ‘‘trunk,’’ they do not re-
ally know what you are talking about. So how do you ensure, in
fact, that the patients know enough to answer your survey appro-
priately?
Dr Ibrahimiye. I think you make a very valid point. Obviously,
when we say ‘‘trunk,’’ we mean the torso, but some patients, as you
pointed out, might not understand what we mean, and I do not
believe we made an effort to tell them what we mean by ‘‘trunk.’’988 The Journal of Thoracic and Cardiovascular SurgDrMark J. Krasna (Towson, Md).Ali, thank you. It is actually
a very intriguing paper.
I want to follow-up on one of DrMarshall’s points, which I think
is very important. There is actually a new standard nomenclature
for reporting sympathectomy that has been adopted by both the So-
ciety of Thoracic Surgeons and the International Society of Sympa-
thetic Surgery. I would strongly recommend before your final
version of your manuscript that you go to one of those Web sites
and you will see that. I think what Blair was pointing out is that
what you really did is what would be called an R3-R4 sympathetic
clamping, and that is probably how it should be defined.
I do have 2 questions, though, which I think are very intriguing
to all of us who have been looking at the question of clamping. One
very simple question is did you notice a difference in the operating
timewhen you did clamping versus cutting? You did not tell us, but
did you look for it?
Dr Ibrahimiye.We did not look for it specifically, but this was
a single-surgeon, single-institution experience, and they reported
that there was no significant time difference.
Dr Krasna. My second question has to do with reversibility.
Obviously, one of the benefits proposed for doing clamping versus
cutting is, as you said, the potential for reversibility. Did you actu-
ally have any cases in whom the patients were unhappy and they
went for reversibility, and if those patients underwent a reversal
procedure, was it successful? That is obviously one of the key
questions we would like to know.
Dr Ibrahimiye. Thank you.
In this cohort of 152 patients, we actually had 1 patient who un-
derwent a reversal procedure 1 year after the original procedure,
and this patient did not have any improvement of her symptoms.
It was 1 year after the initial procedure. In addition to that, in
our entire cohort of 362 patients, we had 4 additional patients
who underwent a reversal procedure. Three of these four actually
reported improvement and were able to maintain the benefits of the
original procedure; however, one did not have any change in symp-
toms, and the patient who did not have any change was also 1 year
out of the surgery.
Dr Laureano Molins (Barcelona, Spain). Thank you for your
presentation.
Our experience was with cutting until 2007, 300 patients, and
then 100 more with clipping, and the results were quite similar. I
have 2 questions. One is technical. What kind of clip do you
use? We think that the usual surgical clip, you cannot see the
end. Second, with these conclusions, do you recommend, as we
are doing, clipping versus cutting?
Dr Ibrahimiye. We use the standard 5-mm hemoclip. As you
pointed out, the most important thing that my attending always
tells me is that you have to see the ends of the clips, as you pointed
out, but it is a straight 5-mm hemoclip.
Your second question, we do recommend this procedure for
those patients who have failed medical therapy and in whom hy-
perhidrosis is severely affecting their quality of life, and we always
make them aware of the possibility of compensatory sweating.
Dr Molins. So you have adopted the clipping?
Dr Ibrahimiye. Yes, we have completely adopted the clipping
method.
Dr Michael A. Maddaus (Minneapolis, Minn). You indicated
that you do a T3 and T4 clipping routinely. Is that right?ery c November 2010
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DrMaddaus. Is that for all comers, kind of like a Nissen for all
refluxers? In other words, for people who have axillary hyperhi-
drosis, do you do a T3-T4? You know, when you get the
occasional patient with a foot problem, do you do a T3-T4? Do
you differentiate in any way what levels you clip, or is everybody
a T3-T4?
Dr Ibrahimiye. Everybody in this study cohort had palmar hy-
perhidrosis, so they all underwent the same procedure. I have not
had any experience with axillary hyperhidrosis. Perhaps, Dr Gor-
enstein might be able to answer your question.
Dr Lyall A. Gorenstein (New York, NY). The only operation
we do basically is for patients who have palmar hyperhidrosis. So
the axillaries, the plantars, et cetera, they are treated in other
ways.
Dr Maddaus. You do not do it for axillary then?
Dr Gorenstein. No.
Dr Maddaus. Anything for the head?
Dr Gorenstein. No.
Dr Maddaus. Any experience with that?The Journal of Thoracic and CaDr Gorenstein.We did in the past and stopped doing it because
of bad outcomes, either disappointed patients or severe compensa-
tory sweating, and do not recommend it.
Dr Joseph B. Shrager (Stanford, Calif). It has become tradi-
tional when there is a paper on hyperhidrosis to poll the audience
to see what people do.
For isolated palmar hyperhidrosis, who does T4 only?
(A show of hands.)
Dr Shrager. One. Who does T3 only?
(A show of hands.)
Dr Shrager. Who does T3 and T4?
Dr Krasna. R3-R4.
Dr Shrager. Okay. Sorry, Dr Krasna. R3 and R4?
(A show of hands.)
Dr Shrager. Who does R2 through R4?
(A show of hands.)
Dr Shrager. Just R2? Any others just R2?
(A show of hands.)
Dr Shrager. I know you have changed, then, Blair, because that
is not what you told me a year ago.rdiovascular Surgery c Volume 140, Number 5 989
